Labcorp Beats Q1 Revenue Estimates, Provides In-Line FY EPS Outlook
Summary
Labcorp reported first-quarter revenue of $3.54 billion, surpassing the IBES estimate of $3.505 billion, indicating a modest beat for the quarter. The company also issued a full-year adjusted EPS outlook of $17.70-$18.35, which encompasses the IBES estimate of $17.90, suggesting expectations are being met. This financial update provides a positive signal regarding the company's operational execution and outlook, following its strong 2025 financial results. Traders will monitor future reports for continued revenue growth and any shifts in the EPS guidance range.
At the time of this announcement, LH was trading at $257.14 on NYSE in the Life Sciences sector, with a market capitalization of approximately $21.1B. The 52-week trading range was $218.76 to $293.72. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.